Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Heath

Showing results (71-80 of 248) with videos related to

Pageof 25
Sort By:
BMJ (Clinical Research Ed.)|March 6, 2015
The challenge of overdiagnosis begins with its definitionS M Carter, W Rogers, I Heath, et al.
Cancer Cell|May 11, 2021
Metastatic urothelial carcinomaMargaret Knowles, Lars Dyrskjøt, Elisabeth I Heath, et al.
Biochemical Society Transactions|November 1, 1993
Dysregulation of T cell-macrophage network in severe acute pancreatitisC Chaloner, I Laing, D I Heath, et al.
Scientific Reports|January 10, 2018
Adipocyte-activated oxidative and ER stress pathways promote tumor survival in bone via upregulation of Heme Oxygenase 1 and SurvivinMackenzie K Herroon, Erandi Rajagurubandara, Jonathan D Diedrich, et al.
Clinical Genitourinary Cancer|July 21, 2022
Treatment Intensification Patterns and Utilization in Patients with Metastatic Castration-Sensitive Prostate CancerElisabeth I Heath, Gregory E Dyson, Frank C Cackowski, et al.
The Prostate|February 8, 2022
Alcohol dehydrogenase expression patterns in normal prostate, benign prostatic hyperplasia, and prostatic adenocarcinoma in African American and Caucasian menSarah A Stamis, Elisabeth I Heath, Steven Lucas, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|July 7, 2009
Earlier diagnosis and treatment of symptomatic bowel cancer: can it be achieved and how much will it improve survival?M R Thompson, I Heath, E T Swarbrick, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 26, 2000
Mutations in beta-catenin and APC genes are uncommon in esophageal and esophagogastric junction adenocarcinomasY W Choi, E I Heath, R Heitmiller, et al.
Investigational New Drugs|October 17, 2007
A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumorsElisabeth I Heath, Keith Bible, Robert E Martell, et al.
Gut|January 1, 1993
Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitisD I Heath, A Cruickshank, M Gudgeon, et al.
Pageof 25

Showing results (71-80 of 248) with videos related to

Sort By:
Pageof 25
BMJ (Clinical Research Ed.)|March 6, 2015
The challenge of overdiagnosis begins with its definitionS M Carter, W Rogers, I Heath, et al.
Cancer Cell|May 11, 2021
Metastatic urothelial carcinomaMargaret Knowles, Lars Dyrskjøt, Elisabeth I Heath, et al.
Biochemical Society Transactions|November 1, 1993
Dysregulation of T cell-macrophage network in severe acute pancreatitisC Chaloner, I Laing, D I Heath, et al.
Scientific Reports|January 10, 2018
Adipocyte-activated oxidative and ER stress pathways promote tumor survival in bone via upregulation of Heme Oxygenase 1 and SurvivinMackenzie K Herroon, Erandi Rajagurubandara, Jonathan D Diedrich, et al.
Clinical Genitourinary Cancer|July 21, 2022
Treatment Intensification Patterns and Utilization in Patients with Metastatic Castration-Sensitive Prostate CancerElisabeth I Heath, Gregory E Dyson, Frank C Cackowski, et al.
The Prostate|February 8, 2022
Alcohol dehydrogenase expression patterns in normal prostate, benign prostatic hyperplasia, and prostatic adenocarcinoma in African American and Caucasian menSarah A Stamis, Elisabeth I Heath, Steven Lucas, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|July 7, 2009
Earlier diagnosis and treatment of symptomatic bowel cancer: can it be achieved and how much will it improve survival?M R Thompson, I Heath, E T Swarbrick, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 26, 2000
Mutations in beta-catenin and APC genes are uncommon in esophageal and esophagogastric junction adenocarcinomasY W Choi, E I Heath, R Heitmiller, et al.
Investigational New Drugs|October 17, 2007
A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumorsElisabeth I Heath, Keith Bible, Robert E Martell, et al.
Gut|January 1, 1993
Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitisD I Heath, A Cruickshank, M Gudgeon, et al.
Pageof 25